Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Patent granted for energy return foot orthotic

Discussion in 'Biomechanics, Sports and Foot orthoses' started by NewsBot, Nov 23, 2017.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    ENERGY RETURN ORTHOTIC SYSTEMS
    Patent attached
     

    Attached Files:

  2. Admin2

    Admin2 Administrator Staff Member

  3. Craig Payne

    Craig Payne Moderator

    Articles:
    8
    Looks like this one is actually coming to market ...
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press release:
    SubioMed Enters Dynamic Biomechanics Market from Minneapolis
    SubioMed Enters Dynamic Biomechanics Market from Minneapolis
    Company Founded on Patented Inventions by Dr. Barry Butler, DPM Practicing Podiatrist and Serial Inventor


    MINNEAPOLIS, May 8, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today announced that it has entered the biomechanics market launching operations in Minneapolis, MN.

    Dr. Barry Butler, a practicing podiatrist, serial inventor and Chairman of the Board for SubioMed, has created the technology that SubioMed intends to commercialize. Dr. Butler is also the Founder and a Partner of Advanced Foot and Ankle Clinics, which was established in 1992. With multiple clinics located in southern Minnesota, Dr. Butler is a 28-year veteran of the space with experience in foot and ankle surgery, orthotics and bracing.

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing Dr. Butler’s technology.

    Dr. Butler stated, “We are very pleased to enter the biomechanics market from the Minneapolis area, the center of medical technology and devices. We look forward to soon announcing the formation of our board of directors, in addition to our management team. We expect our team to consist of world class executives focused on bringing effective biomechanics solutions for patients.”

    Minnesota’s Medical Alley is the top medical technology cluster for innovation in the world. Home to medical technology companies and providers like Medtronic, Mayo Clinic, Boston Scientific, Abbott, Starkey Hearing and many early stage and emerging MedTech companies, the booming medical technology industry in Minnesota has fueled billions of dollars in economic growth, as well as thousands of jobs in medical device manufacturing and assembly. Minnesota medical device manufacturing jobs have grown 14% over the past five years creating some of the best medical technology jobs in the country.

    For more information on SubioMed please visit our website at www.SubioMed.com.
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed™ Bolsters Management With Appointment of Janine Whited as Controller
    Joins Company Comprised of a Team of Accomplished Executives and Industry Veterans Focused on Patented Inventions by Dr. Barry Butler, DPM Practicing Podiatrist and Serial Inventor

    July 01, 2019 08:30 ET | Source: SubioMed
    MINNEAPOLIS, July 01, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today announced the appointment of Janine Whited to the position of Controller. This appointment comes on the heels of multiple accomplished executives having joined its management team in recent months.

    Janine Whited, CPA, joins SubioMed with a 35-year track record in Finance. Prior to joining SubioMed, she was the Chief Financial Officer of J-C Press where she was responsible for treasury management, bank relations, staff development, and executive team strategic planning. While there, she implemented internal controls aimed at maximizing efficiencies within cash management, inventory control and process documentation.

    Early in her career, Whited held the role of staff accountant at Arnow & Associates as well as St. Mary’s Hospital. She received an MBA from the University of Wisconsin at Milwaukee and completed her undergraduate at the University of Iowa.

    Dr. Barry Butler, a practicing podiatrist, Chairman of the Board and creator of the technology that SubioMed intends to commercialize commented, “I’m very pleased to welcome Janine to our management team. I believe her skill sets make her ideally suited for the role of Controller where I expect her to complement our existing management team.”

    Ms. Whited will report to Patrick Kullmann who recently joined SubioMed as CEO with a 35-year track record in MedTech, Biotech and Pharma. He has served in leadership positions at J&J, Boston Scientific and Medtronic and multiple start up medical technology companies. Recently COO and President for Medovex Corp, Patrick has also served as a member of the board of directors for several companies in the past and has been a featured presenter in the US and the EU on topics of MedTech startup topics.

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing Dr. Butler’s technology.

    For more information on SubioMed, please visit our website at www.SubioMed.com.

    About SubioMed
    SubioMed intends to be a pioneer in the invention and development of biomechanics technology addressing gait and balance. Biomechanics is the study of the mechanics of the living body, especially of the forces exerted by muscles and gravity on the skeletal structure.
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed Enters Design and Development Agreement with Minneapolis-Based Nortech Systems
    MINNEAPOLIS, Aug. 05, 2019 (GLOBE NEWSWIRE) — SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today announced that it has entered into a design and development agreement with Minneapolis-based Nortech Systems.

    Brian Bowen, Executive Vice President of SubioMed, stated, “SubioMed is very pleased to begin our product design and development process with the signing of a definitive agreement with Nortech Systems of Minneapolis. We are actively commencing work on our initial products with anticipated commercialization and launch in 2020.”

    Nortech Systems serves the medical device, aerospace and industrial markets from facilities in the U.S. and Mexico where it provides a full range of design, development and manufacturing services for some of the largest medical device companies in the world as well as many early-stage companies in the medical technology space.

    Patrick Kullmann, Chief Executive Officer of SubioMed, stated, “This is a pivotal milestone for the company. We are excited to be entering the commercialization stage of Dr. Barry Butler’s life enhancing inventions. The experienced team of project leaders, mechanical engineers and industrial designers at Nortech Systems perfectly complements our leadership team and technology.”

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Dr. Barry Butler. Dr. Butler has been in practice 28 years and is board certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed™ Selects Moticon Science Smart Sensing Technology for Design and Development Phase
    MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today announced that it has selected Moticon SCIENCE sensing insole technology for foot and ankle biomechanic work.
    Moticon recently released its new sensor insole generation “Insole3,” their industry-leading technology combining on-the-go pressure sensing, inertial measurement, and app-based analytics to provide real-life gait analysis.

    As an important part of SubioMed’s product development and future strategy, the Company has purchased sets of Insole3 along with the accompanying software from Moticon, a leading provider in the field located in Munich, Germany. Realtime pressure sensing and gait analytics are key parameters for biomechanic assessment and are expected to be valuable to SubioMed as it moves through the design and development process.

    Dr. Barry Butler, Inventor, Co-Founder, and Chairman of SubioMed stated, "Our investment in the technology from Moticon delivers a key validation tool allowing real-time analysis and evaluation of our products during the design and development process. Additionally, we anticipate Moticon technology may play a key role for us during commercialization."

    Butler continued, “SubioMed’s unique breakthrough value to physicians and ancillary providers is the delivery of product solutions via the combination of objective measurements with clinical impressions. This represents the future of the treatment for gait disorders in patients and for consumers in the general footwear industry.”

    Maximilian Mueller Ph.D., Moticon co-founder commented, "We are very pleased that SubioMed has selected our Insole3 technology system. The use of our high-performance technology in the development of the SubioMed products will provide their team immediate feedback on the performance characteristics of their product line in real-time during development and beyond."

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
  8. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press release:
    SubioMed to be a Featured Presenter at the Medical Alley Innovation Summit in Minneapolis September 11-12, 2019
    Two-Day Investment and Networking Event Will Feature 40 Pre-Screened Start-Up Medical Technology Companies Delivering 10-Minute Presentations

    August 26, 2019 08:00 ET
    MINNEAPOLIS, Aug. 26, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today announced that it will be a featured presenter at the Medical Alley Innovation Summit in Minneapolis Minnesota September 11-12, 2019.

    Medtech Strategist and Medical Alley have teamed up to host the third annual conference to provide candid insight on critical topics important to all stakeholders in the rapidly evolving global device marketplace. The two-day investment and networking event which will feature thought-leading guest speakers, plenary and panel sessions, and short presentations from 40 selected start-up medical technology companies.

    Patrick Kullmann, SubioMed’s Chief Executive Officer stated, "The Medical Alley Innovation Summit is an excellent opportunity for the investment community and other collaborators to learn more about SubioMed. We look forward to presenting to over 250 top medical device venture capitalists and senior business development executives from Minnesota’s vibrant Medical Alley area and around the world.”

    Kullmann went on to say, “We are very pleased with the fundraising and operating progress SubioMed has made to date. We anticipate building additional momentum through this presentation opportunity."

    SubioMed is a Minnesota Angel Tax Accredited company, located in Bloomington, MN.

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Dr. Barry Butler. Dr. Butler has been in practice 28 years and is board certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).

    For more information on SubioMed, please visit our website at www.SubioMed.com.

    About SubioMed:
    SubioMed intends to be a pioneer in the invention and development of biomechanics technology addressing gait and balance. Biomechanics is the study of the mechanics of the living body, especially of the forces exerted by muscles and gravity on the skeletal structure.
     
  9. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed to Attend American Orthopedic Foot and Ankle Society Annual Meeting in Chicago
    September 9, 2019
    Largest Meeting of its Kind for Foot and Ankle Orthopedics Featuring World Class Companies Including Wright Medical, Depuy, Zimmer Bionet and Stryker
    MINNEAPOLIS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that it will be attending the American Society of Foot and Ankle Annual Meeting being held September 12-15, 2019 in Chicago.

    The premier meeting for orthopedic foot and ankle education, the AOFAS Annual Meeting features renowned speakers, the latest research and surgical advancements, and opportunities to connect with orthopedic specialists from around the world.

    Brian Bowen, Executive VP for SubioMed, Inc. will attend this world-class meeting where he will participate in targeted meetings with physicians and corporate leaders in the medical and consumer space with the intent to explore collaborative co-development, investment, and distribution opportunities.

    “Attending the highly respected AOFAS Annual Meeting is beneficial to SubioMed as we further develop our portfolio and execute our commercialization strategy. Importantly, influential physicians and corporate leaders with whom we would consider working will be present, along with potential future investors,” commented Mr. Bowen.

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
  10. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  11. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  12. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  13. Ted Dean

    Ted Dean Member

    Different materials but similar concepts to Z-Coil shoes and Dr. King's orthotic. Be interesting to hear others thoughts.
     
  14. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed Corporation Appoints New Chairman of the Board
    Veteran MedTech Industry Leader and CEO Named Chairman

    March 16, 2020 08:30 ET
    MINNEAPOLIS, March 16, 2020 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that it has appointed veteran Medtech industry leader Patrick Kullmann Chairman of its board of directors.

    Mr. Kullmann assumed the role of Chairman in addition to his duties as Chief Executive Officer, effective February 19, 2020. Kullmann is Co-founder of SubioMed and previously served in leadership positions at Johnson & Johnson, Boston Scientific and Medtronic and multiple start up medical technology companies. Most recently, he served as President and COO for publicly listed Medovex Corp.

    Patrick has also served as a member of the board of directors for several companies in the past and has been a featured presenter in the U.S. and the EU on topics of MedTech startup topics. Highly qualified and accomplished in the startup space with a proven track record of success in the medical technology field. Patrick is the author of the book “The Inventors Guide for Medical Technology” and is a Fox Business News network contributor. SubioMed is his eighth start up. He has successfully team raised funding in private and public markets.

    Barry Butler, DPM, Founder and Chief Medical Officer of SubioMed, Inc. stated, “We are very pleased to make this announcement as part of our strategic plan of continuously increasing our leadership and experience capabilities of the board of directors. Patrick Kullmann has served the company very well since its formation and will continue to service very well in this new and additional role as Chairman of the Board.”

    Butler continued, “Mr. Kullmann the highest level of experience in the industry and in the funding and operating spaces. We could not be happier with this latest appointment coming on the heels of the two newly appointed board members, Mr. Gary Peterson and Mr. Michael McBrayer.”

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
  15. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Another patent approved:
    Energy return orthotic systems


     
  16. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed Corporation Announces Successful Completion of Financing
    MedTech Start-Up Closes $1.5 Million Investment Round and Targets Launch of its Patented Suspension Biomechanics Technology

    June 24, 2020 08:00 ET
    MINNEAPOLIS, June 24, 2020 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of disruptive Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that it has successfully completed its initial equity financing round of $1.5M.

    The common stock offering saw insider participation, in addition to investments from individual angel investors.

    Patrick Kullmann, Chairman and Chief Executive Officer of SubioMed stated, “We are very pleased to have successfully completed this early round of financing which paves the way for future growth. We are grateful to our investors who share our vision and passion for providing solutions capable of addressing physical issues surrounding biomechanics of the lower extremities, which are a leading cause of morbidity and mortality affecting millions of patients worldwide.”

    Proceeds from the financing will be used to further the development of its first products which SubioMed anticipates launching in early 2021.

    SubioMed intends to commercialize technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
  17. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SubioMed Corporation Appoints New Chief Executive Officer
    Veteran MedTech Industry Leader Named Chief Executive Officer
    June 29, 2020 08:00 ET
    MINNEAPOLIS, June 29, 2020 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of disruptive Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that it has appointed veteran MedTech industry leader Gary Peterson, to the position of Chief Executive Officer.

    SubioMed welcomes Mr. Gary Peterson to the position as Chief Executive Officer, effective, July 1, 2020. Mr. Peterson has 45+ years of experience in the medical device, health services and finance business. Over the last six years he held top executive positions in the orthopaedic and regenerative medicine fields with world famous The Steadman Clinic, the Steadman Philippon Research Institute, and associated ventures in Vail, Colorado. Gary has served on numerous public and private company boards, founded and managed several venture funding organizations, and held top operating roles in companies including Angiomedics as its co-founder, along with significant marketing roles at Cardiac Pacemakers, Inc.

    Patrick Kullmann, Chairman and Co-founder of SubioMed, Inc. stated, “We are very pleased to make this announcement as part of our strategic plan of continuously increasing our management team’s leadership and experience capabilities. Gary Peterson has served the company in an outstanding fashion as a board member and outside consultant and he will continue to serve very well in this new and additional role as its Chief Executive Officer.” This appointment follows Mr. Kullmann’s planned retirement June 30, 2020 as CEO, he will remain the Company’s Chairman.

    Kullmann continued, “Mr. Peterson has the highest level of experience in the industry in both the funding and operating spaces. We could not be happier with this latest appointment coming on the heels of our completed initial raise of $1,500,000.”

    Physical issues surrounding biomechanics of the lower extremities are a leading cause of morbidity and mortality effecting millions of patients worldwide. SubioMed intends to address this problem by commercializing technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
     
Loading...

Share This Page